Toggle light / dark theme

Summary: An international team of scientists has identified a gene in the brain responsible for anxiety symptoms and found that modifying the gene can reduce anxiety levels, offering a novel drug target for anxiety disorders. The discovery highlights a new amygdala miR483-5p/Pgap2 pathway that regulates the brain’s response to stress and provides a potential therapeutic approach for anxiety disorders.

Source: University of Bristol.

A gene in the brain driving anxiety symptoms has been identified by an international team of scientists. Critically, modification of the gene is shown to reduce anxiety levels, offering an exciting novel drug target for anxiety disorders.

An anti-cancer gel promises to wipe out glioblastoma permanently, a feat that’s never been accomplished by any drug or surgery. So what makes this gel so special?

Scientists at Johns Hopkins University (JHU) have developed a novel gel that both eliminates brain cancer (glioblastoma) and keeps it from recurring. When they tested this anti-cancer gel on mice with glioblastoma, surprisingly, all the mouse models were cured of the illness.

“We don’t usually see 100% survival in mouse models of this disease,” said Betty Tyler, one of the study authors and a neurosurgery professor at the Johns Hopkins School of Medicine.

A new project called Progression Assessment in Neurodegenerative Disorders of Aging or PANDA aims to detect subtle changes in a person’s sleep patterns that may indicate the onset of Alzheimer’s or Parkinson’s disease. The collaboration of this four-year project involves Rigshospitalet University, Denmark’s Aarhus University, and MedTech company T&W Engineering. The project has received funding of DKK 15 million to develop and test a small earbud-like experimental device that can detect the early signs of these diseases.

The Ear-EEG Technology

Unlike the traditional sleep-monitoring systems that require a person to stay in a clinic with multiple electrodes attached to their body, the ear-EEG allows for comfortable, long-term use at home. The device monitors electrical activity in the brain by measuring tiny voltage changes on the skin surface within the ear canal. It is also equipped with an oximeter for measuring blood oxygen levels, a microphone for monitoring respiration and heart rate, and a thermometer for measuring body temperature.

A study reflects on how these plastic particles can increase the risk of neuroinflammation and neurodegeneration.

We have known for a while that microplastics are in our bloodstreams, making their way into our bodies through daily consumables like milk and meat. The foreign presence of micro and nano-plastic particles (MNPs) in our bodies is dangerous for obvious reasons, and they can potentially reach remote locations and penetrate living cells.

In a scary confirmation of this potentiality, a new study has found that polystyrene, a widely-used plastic found in food packaging, could be detected in the brain just two hours after ingestion.

Last 2020, scientists were able to pick up distinct brain signals that had never been observed before. Such findings hint at how the brain is a more powerful computational device than previously thought.

Distinct Brain Signals

According to Science Alert, back then, researchers from German and Greek institutes were able to report a brain mechanism in the outer cortical cells. They reported their discoveries in the Science journal.

The researchers found those who showed positive age beliefs were 30% more likely to recover from cognitive impairment than those who held negative age beliefs, irrespective of the severity of the cognitive decline. The time for recovery was also quicker in people with positive age beliefs.

They also found that the participants who stayed positive about aging were less likely to develop mild cognitive impairment over 12 years.


It is widely believed that memory loss associated with aging is irreversible. However, a new study says people who embrace aging positively may recover from cognitive decline.

Cognitive decline in older adults includes difficulty in thinking, memory, concentration, and other brain functions. The cognitive impairment may strike all of a sudden or gradually progress with age.

Misfolded proteins are toxic to cells. They disrupt normal functions and cause some age-related human degenerative diseases, like Alzheimer’s, Parkinson’s, and Huntington’s diseases. Cells work constantly to eliminate misfolded proteins, but these clearance mechanisms are still poorly understood.

In a new study published April 20 in Nature Cell Biology, researchers at Stanford University discovered a previously unknown cellular pathway for clearing from the , the compartment where the cell stores, transcribes, and replicates its DNA. Keeping junk away from those processes is critical to normal cellular function. The new pathway could be a target for age-related disease therapies.

To find the new pathway, researchers in the lab of Judith Frydman, the Donald Kennedy Chair in the School of Humanities and Sciences, integrated several genetic, imaging, and biochemical approaches to understand how dealt with misfolded proteins. For the experiments, the team restricted misfolded proteins to either the nucleus or the cytoplasm—the area inside the cell but outside the nucleus. The team visually followed the fate of the misfolded proteins through live-cell imaging and super-resolution microscopy.

An international team led by scientists at the University of Sydney has demonstrated nanowire networks can exhibit both short-and long-term memory like the human brain.

The research has been published today in the journal Science Advances (“Neuromorphic learning, working memory, and metaplasticity in nanowire networks”), led by Dr Alon Loeffler, who received his PhD in the School of Physics, with collaborators in Japan.

Photograph of nanowire network (left), network’s pathways changing and strengthening (right). (Image: Alon Loeffler)